Skip to main content
Fig. 2 | The Journal of Headache and Pain

Fig. 2

From: Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials

Fig. 2

Disposition of participants. *Subject decision was a sum of subject decision and subject/guardian decision. In the EMPOwER study, six randomized participants did not take the study medication and were not formally entered into the DBTP; these participants are counted under the “no study medication” category. Abbreviation: DBTP, double-blind treatment phase

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us